FDA: guidance on development of abuse-deterrent opioid formulations.
- Published in:
- Formulary, 2013, v. 48, n. 2, p. 84
- Publication type:
- Article
Works matching IS 1082801X AND DT 2013 AND VI 48 AND IP 2
Results: 17
1
2
Lack of coordination, copious prescribing drive polypharmacy challenges.
- Published in:
- Formulary, 2013, v. 48, n. 2, p. 83
- By:
- Publication type:
- Article
3
Prenatal vitamins: A review of the literature on benefits and risks of various nutrient supplements.
- Published in:
- Formulary, 2013, v. 48, n. 2, p. 77
- By:
- Publication type:
- Article
4
Canagliflozin: An emerging treatment option for type 2 diabetes mellitus.
- Published in:
- Formulary, 2013, v. 48, n. 2, p. 68
- By:
- Publication type:
- Article
5
Type 2 diabetes: A focus on new guidelines.
- Published in:
- Formulary, 2013, v. 48, n. 2, p. 55
- By:
- Publication type:
- Article
6
FDA actions in brief.
- Published in:
- Formulary, 2013, v. 48, n. 2, p. 54
- Publication type:
- Article
7
Synthetic stool substitute eradicated refractive C difficile.
- Published in:
- Formulary, 2013, v. 48, n. 2, p. 48
- Publication type:
- Article
8
Pipeline preview.
- Published in:
- Formulary, 2013, v. 48, n. 2, p. 53
- Publication type:
- Article
9
Study offers guidance for use of acid-suppressive medications in hospital patients.
- Published in:
- Formulary, 2013, v. 48, n. 2, p. 40
- By:
- Publication type:
- Article
10
Lower copays, use of mail order can reduce disparities in hypertension medication adherence.
- Published in:
- Formulary, 2013, v. 48, n. 2, p. 52
- By:
- Publication type:
- Article
11
Probiotics can considerably minimize C difficile in hospitals.
- Published in:
- Formulary, 2013, v. 48, n. 2, p. 51
- Publication type:
- Article
12
New molecular entity.
- Published in:
- Formulary, 2013, v. 48, n. 2, p. 53
- Publication type:
- Article
13
Kidney cancer treatment requires focus, consideration of treatment-associated events.
- Published in:
- Formulary, 2013, v. 48, n. 2, p. 47
- Publication type:
- Article
14
High cost, renal complications in diabetes management.
- Published in:
- Formulary, 2013, v. 48, n. 2, p. 52
- Publication type:
- Article
15
Optum, Mayo Clinic partner to promote better patient care.
- Published in:
- Formulary, 2013, v. 48, n. 2, p. 39
- Publication type:
- Article
16
New nonprofit represents specialty pharmacy.
- Published in:
- Formulary, 2013, v. 48, n. 2, p. 39
- Publication type:
- Article
17
Blood pressure agents, NSAID combo linked to kidney risks.
- Published in:
- Formulary, 2013, v. 48, n. 2, p. 33
- By:
- Publication type:
- Article